A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Nitroxoline
Carfentanil
The therapeutic efficacy of Sodium phosphate, monobasic can be decreased when used in combination with Carfentanil.
Nitroxoline
Desomorphine
The therapeutic efficacy of Sodium phosphate, monobasic can be decreased when used in combination with Desomorphine.
Nitroxoline
Dextromoramide
The therapeutic efficacy of Sodium phosphate, monobasic can be decreased when used in combination with Dextromoramide.
Nitroxoline
Etorphine
The therapeutic efficacy of Sodium phosphate, monobasic can be decreased when used in combination with Etorphine.
Nitroxoline
Ethylmorphine
The therapeutic efficacy of Sodium phosphate, monobasic can be decreased when used in combination with Ethylmorphine.
Nitroxoline
Bezitramide
The therapeutic efficacy of Sodium phosphate, monobasic can be decreased when used in combination with Bezitramide.
Nitroxoline
Diamorphine
The therapeutic efficacy of Sodium phosphate, monobasic can be decreased when used in combination with Diamorphine.
Nitroxoline
Dihydroetorphine
The therapeutic efficacy of Sodium phosphate, monobasic can be decreased when used in combination with Dihydroetorphine.
Nitroxoline
Methadyl acetate
The therapeutic efficacy of Sodium phosphate, monobasic can be decreased when used in combination with Methadyl acetate.
Nitroxoline
Aloglutamol
The therapeutic efficacy of Sodium phosphate, monobasic can be decreased when used in combination with Aloglutamol.
Nitroxoline
Ziconotide
The therapeutic efficacy of Sodium phosphate, monobasic can be decreased when used in combination with Ziconotide.
Nitroxoline
Fasudil
The therapeutic efficacy of Sodium phosphate, monobasic can be decreased when used in combination with Fasudil.
Nitroxoline
Xylometazoline
The therapeutic efficacy of Sodium phosphate, monobasic can be decreased when used in combination with Xylometazoline.
Nitroxoline
Iron isomaltoside 1000
Iron isomaltoside 1000 can cause a decrease in the absorption of Sodium phosphate, monobasic resulting in a reduced serum concentration and potentially a decrease in efficacy.
Nitroxoline
Ferric maltol
Ferric maltol can cause a decrease in the absorption of Sodium phosphate, monobasic resulting in a reduced serum concentration and potentially a decrease in efficacy.
Nitroxoline
Ferric oxyhydroxide
Ferric oxyhydroxide can cause a decrease in the absorption of Sodium phosphate, monobasic resulting in a reduced serum concentration and potentially a decrease in efficacy.
Nitroxoline
Tetraferric tricitrate decahydrate
Tetraferric tricitrate decahydrate can cause a decrease in the absorption of Sodium phosphate, monobasic resulting in a reduced serum concentration and potentially a decrease in efficacy.
Nitroxoline
Ferrous fumarate
Ferrous fumarate can cause a decrease in the absorption of Sodium phosphate, monobasic resulting in a reduced serum concentration and potentially a decrease in efficacy.
Nitroxoline
Ferrous succinate
Ferrous succinate can cause a decrease in the absorption of Sodium phosphate, monobasic resulting in a reduced serum concentration and potentially a decrease in efficacy.
Nitroxoline
Ferrous gluconate
Ferrous gluconate can cause a decrease in the absorption of Sodium phosphate, monobasic resulting in a reduced serum concentration and potentially a decrease in efficacy.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3